| Amanta Healthcare Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544502 |
NSE Symbol : AMANTA |
P/E(TTM) : 25.98 |
|
ISIN Demat : INE084K01015 |
Div & Yield% : 0.00 |
EPS(TTM) : 4.11 |
|
Book Value(₹) : 54.26 |
Market Cap(₹Cr) : 414.54 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 74.49 | 70.89 | 65.31 | 72.06 | 67.81 | 66.73 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 74.49 | 70.89 | 65.31 | 72.06 | 67.81 | 66.73 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.68 | 0.07 | 0.96 | 0.16 | 0.87 | 0.21 |
| Total Income | 75.16 | 70.96 | 66.27 | 72.22 | 68.68 | 66.94 |
| Total Expenditure | 59.13 | 58.87 | 50.41 | 53.10 | 52.75 | 52.85 |
| PBIDT | 16.04 | 12.09 | 15.85 | 19.13 | 15.93 | 14.09 |
| Interest | 5.06 | 5.15 | 6.29 | 6.28 | 5.90 | 6.32 |
| PBDT | 10.98 | 6.94 | 9.57 | 12.84 | 10.03 | 7.77 |
| Depreciation | 4.67 | 4.66 | 4.64 | 4.69 | 4.51 | 4.60 |
| Tax | 2.04 | 1.97 | 1.65 | 1.81 | 1.12 | 0.66 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.37 | -0.90 | -0.23 | 0.38 | 0.13 | 0.25 |
| Reported Profit After Tax | 4.63 | 1.21 | 3.51 | 5.96 | 4.28 | 2.26 |
| Extra-ordinary Items | 0.00 | -0.66 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 4.63 | 1.87 | 3.51 | 5.96 | 4.28 | 2.26 |
| EPS (Unit Curr.) | 1.35 | 0.35 | 1.22 | 2.11 | 1.51 | 0.80 |
| EPS (Adj) (Unit Curr.) | 1.35 | 0.35 | 1.22 | 2.11 | 1.51 | 0.80 |
| Calculated EPS (Unit Curr.) | 1.19 | 0.31 | 1.22 | 2.07 | 1.49 | 7.98 |
| Calculated EPS (Adj) (Unit Curr.) | 1.19 | 0.31 | 1.22 | 2.07 | 1.49 | 7.98 |
| Calculated EPS (Ann.) (Unit Curr.) | 4.77 | 1.24 | 4.87 | 8.27 | 5.94 | 31.93 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 4.77 | 1.24 | 4.87 | 8.27 | 5.94 | 31.93 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 38.83 | 38.83 | 28.83 | 28.83 | 28.83 | 2.83 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 21.53 | 17.05 | 24.27 | 26.55 | 23.49 | 21.11 |
| PBDTM(%) | 14.74 | 9.79 | 14.65 | 17.82 | 14.79 | 11.64 |
| PATM(%) | 6.22 | 1.71 | 5.37 | 8.27 | 6.31 | 3.39 |
